Key result
Diabetes self-management support implementation demonstrates early feasibility alongside identifiable operational barriers.
Why the study?
Diabetes is a costly condition with complications and comorbidities that interfere with self-management, although many complications can be prevented or delayed through preventive care and self-management.
Answers are grounded in this paper and cite their sources.
Highlights the substantial economic and health burden of diabetes in the United States and the role of preventive care and self-management in preventing or delaying complications.
Diabetes, a serious and costly condition, is characterized by illness and death from long-term microvascular and macrovascular complications (1). Additionally, numerous and well-known comorbidities can accompany diabetes, including cardiovascular disease, retinopathy, amputations, and nephropathy (1). Often these complications and comorbidities interfere with a person’s ability to self-manage their diabetes (2). The Centers for Disease Control and Prevention (CDC) projects that as many as 1 in 3 adults could have diabetes by 2050 (3). In 2012, the United States spent an estimated $245 billion on diabetes care, including $176 billion in direct medical costs and $69 billion in indirect costs from lost workdays, restricted activity, disability, and early death (4). Many costly complications among people with diabetes can be prevented or delayed with appropriate preventive care and self-management (5).
No takes yet. Share an insight, caveat, or question.
Morgan et al. (2018) studied Diabetes. Diabetes Self-Management Education and Support (DSMES) Programs was evaluated. Preventive care and self-management can prevent or delay diabetes complications, which cost the US an estimated $245 billion in 2012.
Synapse has enriched 10 related papers. Consider them for comparative context: